Dasatinib 70 mg · Strip

Nextnib 70 Mg Tablet

Rx (Prescription Medicine)

USD $ 120.00

USD $ 2.00 per tablet

Upload prescription Ask about this medicine
  • Dispatched from licensed pharmacy partners
  • Tracked worldwide shipping
  • Secure payment

Nextnib 70mg Tablet is a targeted cancer therapy that inhibits specific proteins essential for cancer cell growth. It is used for specific types of cancer with identified genetic mutations.

Key facts

Active ingredient
Dasatinib
Strength
70 mg
Form
Tablet
Drug class
Generic
Brand
Nextnib
Manufacturer
Celon Laboratories
Pack sizes
60 Tablets

Description

Nextnib 70mg Tablet is a targeted therapy medication used in the treatment of certain types of cancer. Its active ingredient is believed to be a tyrosine kinase inhibitor, which works by blocking specific proteins that cancer cells need to grow and divide. By inhibiting these pathways, Nextnib helps to slow down or stop the progression of the disease. It is primarily indicated for patients with specific genetic mutations in their tumors, making it a personalized approach to cancer treatment. The dosage and duration of treatment are determined by a qualified healthcare professional based on the individual’s condition and response to therapy. Common side effects may include fatigue, diarrhea, nausea, rash, and elevated liver enzymes. Patients should inform their doctor about any pre-existing medical conditions and other medications they are taking. Store Nextnib 70mg Tablets at room temperature, away from moisture and direct sunlight.

Additional information

Medicine Form

Tablet

Rx Status

Prescription Required

Medicine Type

Allopathy

Molecule

Nintedanib

Brand Name

Nextnib

Strength

70mg

Brand Name

Molecule

Strength

70 mg

Medicine Form

Tablet

Pack Quantity

60 Tablets

Packaging Type

Strip

Medicine Type

Generic

Country Of Origin

India

Rx Status

Rx (Prescription Medicine)

Same molecule & strength

Other brands of Dasatinib 70 mg — the same active ingredient at the same strength, from a different manufacturer.

On this page
  1. Key facts
  2. Description
  3. Additional information
  4. Same molecule

Content integrity

Medically reviewed by

Renu Meena, B.Pharm

Medical Content Writer

Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.

Last reviewed 11/08/2026

Shipping to your country

Options
Fast Delivery – Arrives in 7–12 Days, Express shipping (Arriving in 3-7 days )
Free over
USD $ 200.00